Zouboulis, C. C., M. M. Okun, R. Gniadecki, P. A. Foley, C. Lynde, J. Weisman, P. Karunaratne, and D. A. Williams. “Adalimumab Efficacy in Hidradenitis Suppurativa Patients Is Sustained at Least Three Years With Weekly Dosing: Results from a Phase 3 Open-Label Extension Study (PIONEER)”. SKIN The Journal of Cutaneous Medicine, vol. 1, no. 3.1, Oct. 2017, p. s128, doi:10.25251/skin.1.supp.127.